Differentiation of human adult CD34+ stem cells into cells with a neural phenotype: role of astrocytes.
It has recently been reported that adult hematopoietic stem cells can differentiate into neural cells, opening new frontiers in therapy for neurodegenerative diseases. In this study, adult human hematopoietic stem cells (HSCs) were isolated via magnetic bead sorting, using a specific CD34 antibody and cultured with human astrocyte culture conditioned medium (ACM). In order to evaluate their differentiation into neurons and/or astrocytes, ACM-treated cultures were probed for the expression of several neural markers. We observed morphological modifications and, after 20 days of treatment, cell morphology displayed extending processes. Immunocytochemistry, Western blotting and RT-PCR showed the expression of neuronal markers such as neurofilaments, neuron specific enolase (NSE) and NeuN in ACM-treated HSCs cultured in poly-L-lysine-coated dishes. On the contrary, when the same ACM-treated cells were grown on a plastic substrate, they expressed high levels of glial fibrillary acidic protein (GFAP), with only weak expression of neuronal markers. Nestin, a neural progenitor cell marker, was present in treated cells, regardless of the substrate. These results demonstrate that astrocytes can generate a suitable microenvironment for inducing HSCs to differentiate into neural cells. Therefore, adult bone marrow may represent a readily accessible source of cells for treating neurodegenerative diseases.
Reali
Camilla
C
Department of Cytomorphology, University of Cagliari, Italy.
Scintu
Franca
F
Pillai
Rita
R
Cabras
Stefano
S
Argiolu
Francesca
F
Ristaldi
Maria Serafina
MS
Sanna
Maria Adele
MA
Badiali
Manuela
M
Sogos
Valeria
V
D018952:Antigens, CD34 / Q000378:metabolism*; D001253:Astrocytes / Q000502:physiology*; D015153:Blotting, Western / Q000379:methods; D001921:Brain / Q000166:cytology* / Q000196:embryology; D002452:Cell Count; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology*; D048429:Cell Size; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000494:pharmacology; D005333:Fetus; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D010641:Phenotype; D011107:Polylysine / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D013234:Stem Cells / Q000187:drug effects / Q000502:physiology*
D018952:Antigens, CD34; D017077:Culture Media, Conditioned; D005904:Glial Fibrillary Acidic Protein; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D011107:Polylysine